The past 15 years were revolutionary for the microbiology field. Technological advances allowed microbial ecosystems to be characterized to unprecedented depth, including the human body. What started as descriptive research and mere associations between bacterial populations and health and disease states progressed into causal research focused on our microbial partners’ role in our health. Although there is still a lot to learn, intervention therapies are already being tested clinically. In 2020 alone, microbiome research received over 1 billion US$ in funding, and companies working on the microbiome received close to 2 billion US$ in venture funding. Click to listen and join this revolutionary hour of discussion on this exciting probiotic opportunity with Ines Martinez, R&D Manager for Health and Nutrition division from SACCO System, together with our Hosts Steve Sowerby and Dave McCaughan.